EGFR and cancer: Similarly, cancer cells resistant to platinum-derived agents or to Epidermal Growth Factor Receptor (EGFR), inhibitors develop an addiction to CIC-mediated promotion of mitochondrial respiration, and inhibition of CIC leads to synthetic lethality [10].